Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Apr 21st.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short changes in Galaxy Ent, Baba, East Buy, Anta Sports, Zijin Mining, Li Auto.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Apr 21st.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short changes in Galaxy Ent, Baba, East Buy, Anta Sports, Zijin Mining, Li Auto.


HK Short Interest Weekly: Galaxy Ent, Baba, East Buy, Anta Sports, Zijin Mining, Li Auto

China/Asia TMT

Shawn Yang

China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

Thematic (Sector/Industry)

<ul>
<li>We see the future, post decoupling world to have two operating systems, one surrounding US and the other surrounding China.</li>
<li>Both US and China will develop respective partners to complete their ecosystems. We will soon have a world running on two sets of standards</li>
<li>While the western world dominates the old order and the new frontiers, China is leading in the new order of energy, drug and manufacturing.</li>
</ul>


We see the future, post decoupling world to have two operating systems, one surrounding US and the other surrounding China.
Both US and China will develop respective partners to complete their ecosystems. We will soon have a world running on two sets of standards
While the western world dominates the old order and the new frontiers, China is leading in the new order of energy, drug and manufacturing.


[Blue Lotus Sector Update]: All Will Have a Bright Future

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Apr 14th.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short changes in Li Auto, Wuxi Bio, Baba, Tencent, Sensetime.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Apr 14th.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short changes in Li Auto, Wuxi Bio, Baba, Tencent, Sensetime.


HK Short Interest Weekly: Li Auto, Wuxi Bio, Baba, Tencent, Sensetime

Equity Bottom-Up

<ul>
<li>China just announced game approval for April batch. The number of games approved is in-line with the pace of approval in recent month.</li>
<li>Pace of China game approval stays flattish, at a much slower pace than pre-tightening.</li>
<li>Both Tencent and Netease received approval for none. Tencent is behind its peers since the approval resumed.</li>
</ul>


China just announced game approval for April batch. The number of games approved is in-line with the pace of approval in recent month.
Pace of China game approval stays flattish, at a much slower pace than pre-tightening.
Both Tencent and Netease received approval for none. Tencent is behind its peers since the approval resumed.


<ul>
<li>We estimate that NetEase's 1Q23 revenue/non-GAAP net income is 1.4%/9.4% vs cons; and 2023's is 7.5%/12.3% vs cons. We suggest that &lt;Eggy Party&gt; has a lot of similarities with &lt;Roblox&gt;.</li>
<li>Four things the market may underestimate about NetEase: 1) the life cycle of &lt;Eggy Party&gt;; 2) &lt;Eggy Party&gt;'s overseas launch; 3)&lt;Justice Mobile&gt;; and 4) AIGC.</li>
<li>We raise NetEase's TP from US$ 99 to US$ 106, and this remains to be one of our top BUY ideas in China internet.</li>
</ul>


We estimate that NetEase's 1Q23 revenue/non-GAAP net income is 1.4%/9.4% vs cons; and 2023's is 7.5%/12.3% vs cons. We suggest that &lt;Eggy Party&gt; has a lot of similarities with &lt;Roblox&gt;.
Four things the market may underestimate about NetEase: 1) the life cycle of &lt;Eggy Party&gt;; 2) &lt;Eggy Party&gt;'s overseas launch; 3)&lt;Justice Mobile&gt;; and 4) AIGC.
We raise NetEase's TP from US$ 99 to US$ 106, and this remains to be one of our top BUY ideas in China internet.


[NetEase (NTES US, BUY, US$106) TP Change]: Eggy Party Could Be Compared to Roblox

China

NetEase, Inc. is an Internet technology company that develops applications, services and other Internet technologies in China. The Company's core businesses consist of email service, web portal and online entertainment, including online gaming services. NetEase also offers online advertising, search, mobile applications and e-commerce.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

NetEase Inc (NTES US)

HK Short Interest Weekly: Galaxy Ent, Baba, East Buy, Anta Sports, Zijin Mining, Li Auto

We analyzed the latest HK SFC report for aggregate short position as of Apr 21st and highlight short interest changes in Galaxy Ent, Baba, East...

Ke Yan, CFA, FRM

[Blue Lotus Sector Update]: All Will Have a Bright Future

We see the future, post decoupling world to have two operating systems, one surrounding US and the other surrounding China.

Blue Lotus Research Institute

HK Short Interest Weekly: Li Auto, Wuxi Bio, Baba, Tencent, Sensetime

We analyzed the latest HK SFC report for aggregate short position as of Apr 14th and highlight short interest changes in Li Auto, Wuxi Bio, Baba,...

Ke Yan, CFA, FRM

Tencent/Netease: Zeroed in April

We analyzed the game approval announced last night for Chinese players. Both Tencent and Netease received approval for none.

Ke Yan, CFA, FRM

[NetEase (NTES US, BUY, US$106) TP Change]: Eggy Party Could Be Compared to Roblox

Four things the market may underestimate about NetEase: 1) the life cycle of ; 2)Eggy Party 's overseas launch; 3) Justice Mobile; and 4) AIGC.

Blue Lotus Research Institute

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)